$QBTS
D-Wave Quantum Inc Stock $qbts

$qbts Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000190798223000011 Filed on April 18, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.583M	$2.395M	$7.173M
YoY Change
Cost Of Revenue	$1.162M	$1.065M	$2.923M
YoY Change	98.97%	-39.14%	67.03%
Gross Profit	$421.0K	$1.330M	$4.250M
YoY Change	-62.71%	-70.63%	-6.16%
Gross Profit Margin	26.6%	55.53%	59.25%
Selling, General & Admin	$14.20M	$12.06M	$31.61M
YoY Change	170.61%	-33.29%	72.3%
% of Gross Profit	3371.97%	906.69%	743.69%
Research & Development	$10.92M	$10.30M	$32.10M
YoY Change	67.28%	-59.44%	27.72%
% of Gross Profit	2592.64%	774.59%	755.32%
Depreciation & Amortization	$339.0K	$385.0K	$1.423M
YoY Change	-17.72%	-74.9%	-7.24%
% of Gross Profit	80.52%	28.95%	33.48%
Operating Expenses	$25.11M	$22.36M	$63.71M
YoY Change	1048.04%	2658.34%	1584.67%
Operating Profit	-$24.69M	-$21.03M	-$59.46M
YoY Change	2233.01%	-665.6%	-8055.74%
Interest Expense	$454.0K	$8.198M	$4.633M
YoY Change	878.87%	-129.8%	3610.85%
% of Operating Profit
Other Income/Expense, Net	$82.00K	$44.00K	$7.929M
YoY Change	-106.4%	-99.84%	-71.59%
Pretax Income	-$24.61M	-$12.79M	-$51.53M
YoY Change	619.01%	3091.19%	-312.44%
Income Tax
% Of Pretax Income
Net Earnings	-$24.60M	-$12.79M	-$51.50M
YoY Change	618.77%	3010.32%	-312.41%
Net Earnings / Revenue	-1554.01%	-533.99%	-717.97%
Basic Earnings Per Share	-$0.20		-$0.43
Diluted Earnings Per Share	-$0.20	-$0.11	-$0.43
COMMON SHARES
Basic Shares Outstanding	80.39M shares	63.10M shares	119.6M shares
Diluted Shares Outstanding	123.1M shares		119.6M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.988M	$7.065M	$7.065M
YoY Change	29129.27%	5564.69%	5564.69%
Cash & Equivalents	$8.988M	$7.065M
Short-Term Investments
Other Short-Term Assets	$2.814M	$3.643M	$3.643M
YoY Change	2181.13%	1967.3%	1967.3%
Inventory	$2.240M	$2.196M	$2.196M
Prepaid Expenses
Receivables	$542.0K	$757.0K	$1.021M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.91M	$13.93M	$13.93M
YoY Change	9576.21%	-27.31%	4527.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.041M	$2.294M	$11.43M
YoY Change	-82.0%	-29.39%	-3.38%
Goodwill
YoY Change
Intangibles	$228.0K	$244.0K
YoY Change		-10.29%
Long-Term Investments			$1.168M
YoY Change			-99.61%
Other Assets	$1.351M	$1.351M	$183.0K
YoY Change	-0.22%	-0.15%	-0.54%
Total Long-Term Assets	$12.55M	$13.02M	$13.02M
YoY Change	-95.82%	-3.2%	-95.66%
TOTAL ASSETS
Total Short-Term Assets	$14.91M	$13.93M	$13.93M
Total Long-Term Assets	$12.55M	$13.02M	$13.02M
Total Assets	$27.46M	$26.95M	$26.95M
YoY Change	-90.86%	-17.37%	-91.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.067M	$6.215M	$6.215M
YoY Change	164.32%	115.12%	194.69%
Accrued Expenses	$9.859M	$6.687M	$5.716M
YoY Change	26.19%	85.03%	9.06%
Deferred Revenue	$1.827M	$1.781M
YoY Change		-33.17%
Short-Term Debt	$420.0K	$420.0K	$420.0K
YoY Change	110.0%
Long-Term Debt Due	$790.0K	$1.671M	$1.671M
YoY Change	-94.83%	659.55%	545.17%
Total Short-Term Liabilities	$18.08M	$15.85M	$15.85M
YoY Change	266.85%	53.94%	448.54%
LONG-TERM LIABILITIES
Long-Term Debt	$8.260M	$7.811M	$7.811M
YoY Change		-36.15%
Other Long-Term Liabilities	$8.428M	$0.00	$9.202M
YoY Change	-62.66%	-100.0%	-56.77%
Total Long-Term Liabilities	$8.260M	$7.811M	$17.01M
YoY Change	-63.4%	-36.24%	-20.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.08M	$15.85M	$15.85M
Total Long-Term Liabilities	$8.260M	$7.811M	$17.01M
Total Liabilities	$34.77M	$32.86M	$32.86M
YoY Change	26.45%	11.05%	35.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$401.4M	-$376.8M
YoY Change		15.84%
Common Stock	$12.00K	$11.00K
YoY Change		-99.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.313M	-$5.914M	-$5.914M
YoY Change
Total Liabilities & Shareholders Equity	$27.46M	$26.95M	$26.95M
YoY Change	-90.86%	-17.37%	-91.03%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$24.60M	-$12.79M	-$51.50M
YoY Change	618.77%	3010.32%	-312.41%
Depreciation, Depletion And Amortization	$339.0K	$385.0K	$1.423M
YoY Change	-17.72%	-74.9%	-7.24%
Cash From Operating Activities	-$13.60M	-$10.89M	-$45.20M
YoY Change	4526.32%	7697.59%	4609.12%
INVESTING ACTIVITIES
Capital Expenditures	$64.00K	$182.0K	$423.0K
YoY Change	-144.44%	-109.1%	-121.16%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$76.00K	-$182.0K	-$498.0K
YoY Change	-47.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$40.00M
YoY Change
Debt Paid & Issued, Net	$881.0K		$21.51M
YoY Change	6676.92%		5291.23%
Cash From Financing Activities	$15.59M	4.298M	$43.27M
YoY Change	7696.0%	27188.89%
NET CHANGE
Cash From Operating Activities	-$13.60M	-10.89M	-$45.20M
Cash From Investing Activities	-$76.00K	-182.0K	-$498.0K
Cash From Financing Activities	$15.59M	4.298M	$43.27M
Net Change In Cash	$1.923M	-6.771M	-$2.418M
YoY Change	-2146.4%	5366.21%	151.92%
FREE CASH FLOW
Cash From Operating Activities	-$13.60M	-$10.89M	-$45.20M
Capital Expenditures	$64.00K	$182.0K	$423.0K
Free Cash Flow	-$13.66M	-$11.07M	-$45.62M
YoY Change	9011.16%	-695.31%	-4490.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001907982
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	qbts	Government Assistance Interest Benefit GovernmentAssistanceInterestBenefit	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41468
CY2022	dei	Entity Registrant Name EntityRegistrantName	D-Wave Quantum Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-1068854
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3033 Beta Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Burnaby
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	BC
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V5G 4M9
CY2022	dei	City Area Code CityAreaCode	604
CY2022	dei	Local Phone Number LocalPhoneNumber	630-1428
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	56760600	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80390676	shares
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2022	dei	Auditor Firm AuditorFirmId	271
CY2022Q4	us-gaap	Cash Cash	7065000	usd
CY2021Q4	us-gaap	Cash Cash	9483000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	757000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421000	usd
CY2022Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	264000	usd
CY2021Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	4774000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2196000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	2114000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3643000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1116000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	0	usd
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1250000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13925000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	19158000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3249000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9133000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8578000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	272000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1353000	usd
CY2022Q4	us-gaap	Assets Assets	26947000	usd
CY2021Q4	us-gaap	Assets Assets	32610000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3756000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2109000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6687000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3614000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1533000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1687000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	220000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2665000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	420000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15848000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10295000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1892000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7301000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6990000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12233000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	32861000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	29590000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	122564333	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	122564333	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	122564333	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	189881000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113335530	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113335530	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2817498	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2817498	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381274000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	148850000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-376797000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-325268000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10402000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10443000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3020000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26947000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32610000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6279000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5160000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2923000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1750000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	915000	usd
CY2022	us-gaap	Gross Profit GrossProfit	4250000	usd
CY2021	us-gaap	Gross Profit GrossProfit	4529000	usd
CY2020	us-gaap	Gross Profit GrossProfit	4245000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32101000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25401000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20411000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21539000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11897000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11587000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10068000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6179000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3714000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	63708000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	43477000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	35712000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-59458000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-38948000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-31467000	usd
CY2022	us-gaap	Interest Expense InterestExpense	4633000	usd
CY2021	us-gaap	Interest Expense InterestExpense	1728000	usd
CY2020	us-gaap	Interest Expense InterestExpense	5257000	usd
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	0	usd
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	7167000	usd
CY2020	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	12027000	usd
CY2022	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	5673000	usd
CY2021	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	0	usd
CY2020	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3873000	usd
CY2022	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	0	usd
CY2021	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	0	usd
CY2020	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	7836000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	1163000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6173000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	629000	usd
CY2021	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	0	usd
CY2020	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1345000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	801000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2969000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7929000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7403000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21448000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51529000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-31545000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10019000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119647777	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119647777	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125342746	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125342746	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127161731	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127161731	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51529000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-31545000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10019000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	41000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-82000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51488000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31530000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10101000	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-103868000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	269000	usd
CY2020	qbts	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	818000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	110000	usd
CY2020	qbts	Stock Exchanged During Period Value StockExchangedDuringPeriodValue	-169146000	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-82000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10019000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	32729000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	82000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1739000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-31545000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3020000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2022	qbts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-16242000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1077000	usd
CY2022	qbts	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	959000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9164000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	41000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51529000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
CY2022Q3	qbts	Reverse Recapitalization Conversion Ratio ReverseRecapitalizationConversionRatio	0.889657
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51529000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-31545000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10019000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1423000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1534000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1886000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	9164000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1739000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2989000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	910000	usd
CY2022	us-gaap	Depreciation Depreciation	1300000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1068000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	840000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	66000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	269000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	246000	usd
CY2022	qbts	Noncash Interest Expense On Debt Instrument NoncashInterestExpenseOnDebtInstrument	0	usd
CY2021	qbts	Noncash Interest Expense On Debt Instrument NoncashInterestExpenseOnDebtInstrument	0	usd
CY2020	qbts	Noncash Interest Expense On Debt Instrument NoncashInterestExpenseOnDebtInstrument	5095000	usd
CY2022	qbts	Noncash Interest Expense On Government Payable NoncashInterestExpenseOnGovernmentPayable	2483000	usd
CY2021	qbts	Noncash Interest Expense On Government Payable NoncashInterestExpenseOnGovernmentPayable	1722000	usd
CY2020	qbts	Noncash Interest Expense On Government Payable NoncashInterestExpenseOnGovernmentPayable	137000	usd
CY2022	qbts	Debt Instrument Noncash Interest And Final Payment Fee DebtInstrumentNoncashInterestAndFinalPaymentFee	1808000	usd
CY2021	qbts	Debt Instrument Noncash Interest And Final Payment Fee DebtInstrumentNoncashInterestAndFinalPaymentFee	0	usd
CY2020	qbts	Debt Instrument Noncash Interest And Final Payment Fee DebtInstrumentNoncashInterestAndFinalPaymentFee	0	usd
CY2022	qbts	Debt Instrument Noncash Amortization Of Commitment Fee DebtInstrumentNoncashAmortizationOfCommitmentFee	175000	usd
CY2021	qbts	Debt Instrument Noncash Amortization Of Commitment Fee DebtInstrumentNoncashAmortizationOfCommitmentFee	0	usd
CY2021	us-gaap	Depreciation Depreciation	1400000	usd
CY2020	qbts	Debt Instrument Noncash Amortization Of Commitment Fee DebtInstrumentNoncashAmortizationOfCommitmentFee	0	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	451000	usd
CY2022	qbts	Non Cash Lease Expense NonCashLeaseExpense	0	usd
CY2021	qbts	Non Cash Lease Expense NonCashLeaseExpense	0	usd
CY2020	qbts	Non Cash Lease Expense NonCashLeaseExpense	201000	usd
CY2022	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	629000	usd
CY2021	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	0	usd
CY2020	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	0	usd
CY2022	qbts	Government Assistance Noncash GovernmentAssistanceNoncash	0	usd
CY2021	qbts	Government Assistance Noncash GovernmentAssistanceNoncash	7140000	usd
CY2020	qbts	Government Assistance Noncash GovernmentAssistanceNoncash	12027000	usd
CY2022	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	5673000	usd
CY2021	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	0	usd
CY2020	qbts	Noncash Interest Income On Government Assistance NoncashInterestIncomeOnGovernmentAssistance	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6173000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	qbts	Interest Benefit Debt Instrument InterestBenefitDebtInstrument	0	usd
CY2021	qbts	Interest Benefit Debt Instrument InterestBenefitDebtInstrument	19000	usd
CY2020	qbts	Interest Benefit Debt Instrument InterestBenefitDebtInstrument	0	usd
CY2022	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	0	usd
CY2021	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	0	usd
CY2020	qbts	Gain Loss On Settlement Of Warrant Liability GainLossOnSettlementOfWarrantLiability	7836000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	1163000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3873000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1257000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	287000	usd
CY2022	qbts	Gain Loss On Share Issuance Under Equity Line Of Credit GainLossOnShareIssuanceUnderEquityLineOfCredit	-75000	usd
CY2021	qbts	Gain Loss On Share Issuance Under Equity Line Of Credit GainLossOnShareIssuanceUnderEquityLineOfCredit	0	usd
CY2020	qbts	Gain Loss On Share Issuance Under Equity Line Of Credit GainLossOnShareIssuanceUnderEquityLineOfCredit	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	337000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-163000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8002000	usd
CY2022	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	-1332000	usd
CY2021	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	-2236000	usd
CY2020	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	9053000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	148000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-182000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	652000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	387000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1012000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3597000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-379000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1279000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	715000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	578000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5579000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-929000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1902000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-335000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-821000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1031000	usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-736000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45226000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34800000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29287000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	423000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1774000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	736000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	75000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	225000	usd
CY2020	us-gaap	Payments For Software PaymentsForSoftware	53000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-498000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1999000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-789000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	43679000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	4100000	usd
CY2021	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	0	usd
CY2020	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	0	usd
CY2022	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	6528000	usd
CY2021	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2020	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2022	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	3159000	usd
CY2021	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	25147000	usd
CY2020	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	542000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1077000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	85000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	20000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	111000	usd
CY2020	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	4250000	usd
CY2021	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2020	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	21511000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1808000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	qbts	Payments Of Government Loans PaymentsOfGovernmentLoans	398000	usd
CY2021	qbts	Payments Of Government Loans PaymentsOfGovernmentLoans	399000	usd
CY2020	qbts	Payments Of Government Loans PaymentsOfGovernmentLoans	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43265000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24913000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43144000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-13000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2418000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11852000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13055000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9483000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21335000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8280000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9483000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21335000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	360000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11870000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4932000	usd
CY2022	qbts	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Resolution Of Contingency RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityResolutionOfContingency	1113000	usd
CY2021	qbts	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Resolution Of Contingency RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityResolutionOfContingency	0	usd
CY2020	qbts	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Resolution Of Contingency RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityResolutionOfContingency	0	usd
CY2022	qbts	Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable	66000	usd
CY2021	qbts	Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable	14000	usd
CY2020	qbts	Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable	-79000	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	420000	usd
CY2021	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2020	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2022	qbts	Warrants Issued WarrantsIssued	8100000	usd
CY2021	qbts	Warrants Issued WarrantsIssued	0	usd
CY2020	qbts	Warrants Issued WarrantsIssued	0	usd
CY2022	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	5294000	usd
CY2021	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	0	usd
CY2020	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	0	usd
CY2022	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	2893000	usd
CY2021	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	0	usd
CY2022	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2020	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	3271000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2020	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	189871000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	0	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1573000	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1474000	usd
CY2022	qbts	Deferred Costs Incurred But Not Yet Paid DeferredCostsIncurredButNotYetPaid	0	usd
CY2021	qbts	Deferred Costs Incurred But Not Yet Paid DeferredCostsIncurredButNotYetPaid	1142000	usd
CY2020	qbts	Deferred Costs Incurred But Not Yet Paid DeferredCostsIncurredButNotYetPaid	0	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	Description of business<div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of the Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger” to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, the Company’s revenue was derived primarily from customers located in the United States, Japan, and Germany.</span></div>
CY2022Q4	qbts	Number Of Board Members NumberOfBoardMembers	7	segment
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-376800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-51500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-31500000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34800000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29300000	usd
CY2022Q4	us-gaap	Cash Cash	7100000	usd
CY2022Q4	qbts	Working Capital Deficit WorkingCapitalDeficit	-1900000	usd
CY2022Q3	qbts	Cash Acquired Through Reverse Recapitalization And Proceeds From Issuance Of Private Placement CashAcquiredThroughReverseRecapitalizationAndProceedsFromIssuanceOfPrivatePlacement	49000000	usd
CY2022Q3	qbts	Payments Of Reverse Capitalization Transaction Costs Including Costs Paid On Behalf Of Related Party PaymentsOfReverseCapitalizationTransactionCostsIncludingCostsPaidOnBehalfOfRelatedParty	14200000	usd
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000	usd
CY2022Q2	qbts	Equity Line Of Credit Ownership Restriction Percentage EquityLineOfCreditOwnershipRestrictionPercentage	0.099
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022Q4	qbts	Equity Line Of Credit Proceeds From Share Issuance Cumulative EquityLineOfCreditProceedsFromShareIssuanceCumulative	4200000	usd
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes as of the date of the consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to COVID-19 and the change could be material in future periods. As of the date of issuance of these consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2022Q4	qbts	Class Of Warrant Or Right Cap On Issuable Number Of Shares Ratio ClassOfWarrantOrRightCapOnIssuableNumberOfSharesRatio	0.361
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2021	qbts	Government Assistance Interest Benefit GovernmentAssistanceInterestBenefit	7200000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	1200000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	600000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	600000	usd
CY2022Q4	us-gaap	Cash Cash	7100000	usd
CY2021Q4	us-gaap	Cash Cash	9500000	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2022Q4	qbts	Class Of Warrant Or Right Quoted Price ClassOfWarrantOrRightQuotedPrice	0.11
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916609	shares
CY2022	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	100000	usd
CY2021	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	1500000	usd
CY2020	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	2100000	usd
CY2020	qbts	Government Assistance Interest Benefit GovernmentAssistanceInterestBenefit	12000000.0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	800000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	900000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1000000.0	usd
CY2022Q3	qbts	Reverse Recapitalization Liabilities Assumed ReverseRecapitalizationLiabilitiesAssumed	16378000	usd
CY2022Q3	qbts	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	2459000	usd
CY2022Q3	qbts	Reverse Recapitalization Net ReverseRecapitalizationNet	37572000	usd
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000.0	usd
CY2022Q3	qbts	Commitment Fee Liability CommitmentFeeLiability	2600000	usd
CY2022Q3	qbts	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18700000	usd
CY2022Q3	qbts	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	9130000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000	usd
CY2022Q3	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	16378000	usd
CY2022Q3	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	14017000	usd
CY2022Q3	qbts	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18735000	usd
CY2022Q3	qbts	Stock Issued During Period Shares New Issues And Reverse Recapitalization StockIssuedDuringPeriodSharesNewIssuesAndReverseRecapitalization	10144040	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110007972	shares
CY2022Q3	qbts	Common Stock Cumulative Shares Forfeited CommonStockCumulativeSharesForfeited	4484425	shares
CY2022Q3	qbts	Reverse Recapitalization Conversion Ratio ReverseRecapitalizationConversionRatio	0.889657
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6279000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5160000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6279000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5160000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	757000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	58000	usd
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	17000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	815000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	438000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2665000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2021Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	21000	usd
CY2022Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	1835000	usd
CY2021Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	2740000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2719000	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4713000	usd
CY2022	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	5325000	usd
CY2021	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	4092000	usd
CY2022	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	6254000	usd
CY2021	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	6086000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2719000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1800000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.99
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2700000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.98
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2170000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2103000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	26000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2196000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	2114000	usd
CY2022Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	2459000	usd
CY2021Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	0	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1858000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1953000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1641000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1108000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	318000	usd
CY2022Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	451000	usd
CY2021Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	175000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2021Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	21000	usd
CY2022Q4	qbts	Financing Liability Current FinancingLiabilityCurrent	0	usd
CY2021Q4	qbts	Financing Liability Current FinancingLiabilityCurrent	39000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6687000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3614000	usd
CY2022Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	391000	usd
CY2021Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	125000	usd
CY2022Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	559000	usd
CY2021Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	531000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	96000	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	151000	usd
CY2022Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	268000	usd
CY2021Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	84000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	697000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	156000	usd
CY2022Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	1449000	usd
CY2021Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	0	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	58000	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	17000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	36000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	52000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3643000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1116000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1168000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	1169000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	183000	usd
CY2020	us-gaap	Depreciation Depreciation	1900000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	184000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1353000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25405000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25050000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23111000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21801000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3249000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1197000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1122000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	953000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	850000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	244000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	272000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29844000	usd
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13624000	usd
CY2022	qbts	Proceeds From Issuance Of Long Term Debt Gross ProceedsFromIssuanceOfLongTermDebtGross	0	usd
CY2021	qbts	Proceeds From Issuance Of Long Term Debt Gross ProceedsFromIssuanceOfLongTermDebtGross	16786000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1808000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022	qbts	Debt Instrument Foreign Exchange Gain Loss DebtInstrumentForeignExchangeGainLoss	1903000	usd
CY2021	qbts	Debt Instrument Foreign Exchange Gain Loss DebtInstrumentForeignExchangeGainLoss	167000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28941000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29844000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	17391000	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11948000	usd
CY2022	qbts	Debt Instrument Discount DebtInstrumentDiscount	0	usd
CY2021	qbts	Debt Instrument Discount DebtInstrumentDiscount	7167000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2483000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1728000	usd
CY2022	qbts	Debt Instrument Discount Government Assistance DebtInstrumentDiscountGovernmentAssistance	5673000	usd
CY2021	qbts	Debt Instrument Discount Government Assistance DebtInstrumentDiscountGovernmentAssistance	0	usd
CY2022	qbts	Debt Instrument Discount Foreign Exchange Gain Loss DebtInstrumentDiscountForeignExchangeGainLoss	-1122000	usd
CY2021	qbts	Debt Instrument Discount Foreign Exchange Gain Loss DebtInstrumentDiscountForeignExchangeGainLoss	4000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19459000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	17391000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	9482000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	12453000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	220000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12233000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	9482000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	12453000	usd
CY2022	qbts	Debt Instrument Impact Of20 Decrease In Revenue Decrease In Carrying Value DebtInstrumentImpactOf20DecreaseInRevenueDecreaseInCarryingValue	500000	usd
CY2022	qbts	Debt Instrument Discount Government Assistance DebtInstrumentDiscountGovernmentAssistance	5700000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1500000	usd
CY2021	us-gaap	Lease Cost LeaseCost	1400000	usd
CY2020	us-gaap	Lease Cost LeaseCost	1600000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	260000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	260000	usd
CY2020	us-gaap	Sublease Income SubleaseIncome	42000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1506000	usd
CY2021	us-gaap	Lease Cost LeaseCost	1355000	usd
CY2020	us-gaap	Lease Cost LeaseCost	1624000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.17
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.18
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.20
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1533000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1341000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1137000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1168000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1199000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7849000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14227000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11214000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-27205000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7784000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-40315000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4340000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2235000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51529000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31545000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10019000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	55430000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	59916000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13304000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13675000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	30064000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	23071000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5943000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5634000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	165000	usd
CY2022Q4	qbts	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	978000	usd
CY2021Q4	qbts	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	547000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	888000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	730000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	107154000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	103191000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100241000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	97143000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6913000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6048000	usd
CY2022Q4	qbts	Deferred Tax Liabilities Convertible Notes DeferredTaxLiabilitiesConvertibleNotes	1000	usd
CY2021Q4	qbts	Deferred Tax Liabilities Convertible Notes DeferredTaxLiabilitiesConvertibleNotes	4000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	315000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	315000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	6597000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	5729000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6913000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6048000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.05
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.03
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.03
CY2022	qbts	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.24
CY2021	qbts	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.02
CY2020	qbts	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	0.18
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.07
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.04
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.50
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	689000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	689000	usd
	qbts	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	121261	shares
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916609	shares
CY2022Q4	qbts	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prior To Exchange Ratio ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPriorToExchangeRatio	11.50
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.91
CY2022Q4	qbts	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.10
CY2022	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdTradingDays	20	day
CY2022	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdConsecutiveTradingDays	P30D
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022	qbts	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2022	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16965849	shares
CY2022	qbts	Share Based Compensation Arrangement By Share Based Payment Award Period Over Which Shares Reserved For Issuance Increases ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOverWhichSharesReservedForIssuanceIncreases	P10Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.05
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12654807	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y4M17D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4369866	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.82
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	105203	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	171204	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.81
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	412132	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.81
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16336134	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	80179000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1500081	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.07
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1380609	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1981000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1050228	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	17832	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.81
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15387546	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8763000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11309426	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.89
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M10D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7056000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4076090	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.86
CY2022	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y8M26D
CY2022Q4	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue	1706000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.11
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.05
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.35
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9700000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3800000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1700000	usd
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9164000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1739000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2989000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y6M
CY2021Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6800000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2022Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	200000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	200000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-51529000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51529000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31545000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31545000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10019000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10019000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119647777	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119647777	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125342746	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125342746	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127161731	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127161731	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	42632045	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17422681	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14147720	shares
CY2022Q4	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000.0	usd
CY2022Q4	qbts	Equity Line Of Credit Right To Sell Common Stock Period EquityLineOfCreditRightToSellCommonStockPeriod	P36M
CY2022Q4	qbts	Equity Line Of Credit Proceeds From Share Issuance Cumulative EquityLineOfCreditProceedsFromShareIssuanceCumulative	4200000	usd
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022	qbts	Common Stock Exchange Ratio CommonStockExchangeRatio	1
CY2022Q4	qbts	Common Shares Voting Rights Votes CommonSharesVotingRightsVotes	1	vote
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7173000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6279000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5160000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11427000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11827000	usd
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	5842000	usd

Files In Submission

Name	View Source	Status
0001907982-23-000011-index-headers.html	Edgar Link	pending
0001907982-23-000011-index.html	Edgar Link	pending
0001907982-23-000011.txt	Edgar Link	pending
0001907982-23-000011-xbrl.zip	Edgar Link	pending
exhibit1037-formofdxwavequ.htm	Edgar Link	pending
exhibit1042-johnempagmtame.htm	Edgar Link	pending
exhibit1043-formofdxwavequ.htm	Edgar Link	pending
exhibit1044-dxwavequantumi.htm	Edgar Link	pending
exhibit1045-dxwavequantumi.htm	Edgar Link	pending
exhibit1046-dxwavequantumi.htm	Edgar Link	pending
exhibit1047-dxwavequantumi.htm	Edgar Link	pending
exhibit211-listofsubs.htm	Edgar Link	pending
exhibit231-2023x04x18conse.htm	Edgar Link	pending
exhibit311-ye2022.htm	Edgar Link	pending
exhibit312-ye2022.htm	Edgar Link	pending
exhibit321-ye2022.htm	Edgar Link	pending
exhibit322-ye2022.htm	Edgar Link	pending
exhibit42-descriptionofsec.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qbts-20221231.htm	Edgar Link	pending
qbts-20221231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qbts-20221231_g1.jpg	Edgar Link	pending
qbts-20221231_g2.jpg	Edgar Link	pending
qbts-20221231_g3.jpg	Edgar Link	pending
qbts-20221231_g4.jpg	Edgar Link	pending
qbts-20221231_g5.jpg	Edgar Link	pending
qbts-20221231_g6.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
qbts-20221231_lab.xml	Edgar Link	unprocessable
qbts-20221231_pre.xml	Edgar Link	unprocessable
qbts-20221231_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qbts-20221231_cal.xml	Edgar Link	unprocessable
qbts-20221231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QBTS
D-Wave Quantum Inc Stock $qbts

2023 Q1 Form 10-K Financial Statement

#000190798223000011 Filed on April 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS D-Wave Quantum Inc Stock $qbts

2023 Q1 Form 10-K Financial Statement

#000190798223000011 Filed on April 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS
D-Wave Quantum Inc Stock $qbts